About this trial
The goal of this study is to evaluate the proportion of assertiveness difficulties in Tourette syndrome. Participants will complete several e-questionnaires (on assertiveness, Tourette severity, quality of life, self-esteem and comorbidities like depression, anxiety...).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Tourette syndrome
Participants aged 18 years or over
Disqualifiers
Participants under legal protection
Inability to complete questionnaires alone
Trial design
Single group
Treatments tested in this trial
Rathus Assertiveness scale
Diagnostic testQuestionnaire completion
Treatment groups
Trial outcomes
Primary outcomes
Rathus assertiveness questionnaire
The Rathus assertiveness questionnaire includes 30 items, each scores from -3 to +30. A total score inferior or equal to -9 reveals assertiveness difficulties.
Secondary outcomes
MOVES
The MOVES is a self-questionnaire including 20 items which measures the severity of the Tourette syndrome. Several scores are defined : motor tics, vocal tics, obsession, compulsion and other phenomena. The higher the score, the greater the severity.
HADS
The HADS is a self-questionnaire to assess depression (7 items) and anxiety (7 items).
ASRS-5
The Adult AD-HD Self-Report Scale (ASRS-5) is a scale to assess the presence of Attention-Deficit / Hyperactivity Disorder. We used the first 6 items of the questionnaire for the screening of ADHD. The total score ranges from 0 to 24 and a cut off of 13 shows good screening performance.
Rosenberg Self-Esteem Scale
The Rosenberg Self-Esteem Scale is a self-questionnaire on self-esteem. It includes 10 items. The lower the score, the lower the self-esteem.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.